Your session is about to expire
← Back to Search
Behavioral Intervention
Mobile Therapy for Depression
N/A
Waitlist Available
Led By Jennifer Dahne, PhD
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18+
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up between baseline and week 12
Awards & highlights
Study Summary
This trial is testing whether a mobile app can help treat depression. Participants will be randomly assigned to either use the app or not, and will be asked to complete electronic questionnaires throughout the study period.
Who is the study for?
This trial is for adults over 18 with depression, as indicated by a score of >10 on the PHQ-9. Participants must be willing to use a mobile app for treatment, own a smartphone compatible with iOS or Android, have an email they check daily or access to text messages, and be enrolled in Epic's MyChart program. Those with current suicidal thoughts are excluded.Check my eligibility
What is being tested?
The study evaluates 'Moodivate', a mobile app designed for treating depression. Over 12 weeks, participants will either receive the app and use it daily or continue their usual care without the app. Their progress will be monitored through electronic questionnaires.See study design
What are the potential side effects?
Since this trial involves using a mobile therapy application rather than medication, traditional side effects are not expected; however, users may experience discomfort if personal issues arise during use.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ between baseline and week 12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~between baseline and week 12
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Mean Score of Depressive Symptoms
Trial Design
3Treatment groups
Experimental Treatment
Group I: Group C- Moodivate + EHRExperimental Treatment1 Intervention
Participants randomized to the Moodivate + EHR condition will receive similar instructions as those randomized to Moodivate, but will also be instructed that their PCP will have access to metrics related to their app utilization and may choose to follow-up with them regarding treatment utilization and response. The PCP for each participant randomized to this condition will be provided EHR access to Moodivate metrics which will include metrics related to change in mood, frequency of app utilization, and frequency of activity completion. Participants will be asked to complete questionnaire measures weekly for 8 weeks, with a final follow-up questionnaire at 12 weeks following study enrollment.
Group II: Group B- MoodivateExperimental Treatment1 Intervention
Participants randomized to the Moodivate condition will be instructed to utilize Moodivate regularly, at least once per day, for the treatment of depressed mood. Participants in the Moodivate group will receive a download code to download the Moodivate mobile application. Moodivate is a mobile app for individuals with elevated symptoms of depression. Within the app, users identify values, create activities, schedule activities, and rate mood daily. Participants will be asked to complete questionnaire measures weekly for 8 weeks, with a final follow-up questionnaire at 12 weeks following study enrollment.
Group III: Group A- Treatment as UsualExperimental Treatment1 Intervention
Participants in the treatment as usual group will be provided educational material about mood management available via the EHR with the suggestion to discuss questions with their PCP. Participants will be asked to complete questionnaire measures weekly for 8 weeks, with a final follow-up questionnaire at 12 weeks following study enrollment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Treatment as Usual
2016
Completed Phase 3
~2710
Behavioral Activation Therapy app
2021
N/A
~110
Find a Location
Who is running the clinical trial?
National Institute of Mental Health (NIMH)NIH
2,789 Previous Clinical Trials
2,689,780 Total Patients Enrolled
667 Trials studying Depression
251,495 Patients Enrolled for Depression
Medical University of South CarolinaLead Sponsor
936 Previous Clinical Trials
7,396,188 Total Patients Enrolled
40 Trials studying Depression
6,303 Patients Enrolled for Depression
National Institutes of Health (NIH)NIH
2,705 Previous Clinical Trials
7,506,636 Total Patients Enrolled
54 Trials studying Depression
46,558 Patients Enrolled for Depression
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are new participants currently being welcomed into this research endeavor?
"According to the clinicaltrials.gov listings, this trial has ceased recruitment of participants despite initial posting on December 10th 2021 and its most recent update occuring February 8th 2022. However, there are 1135 other medical studies currently recruiting candidates for active participation."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger